Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging

By Stępień Ewa   Kabłak-Ziembicka Anna   Czyż Jarosław   Przewłocki Tadeusz   Małecki Maciej  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 677-688

Informa Healthcare

Access to resources Recommend Favorite

Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 22, 2004-08 ,pp. : 2769-2778

Bentham Science Publishers

Access to resources Recommend Favorite

The vascular endothelium in diabetes: a practical target fordrug treatment?

By Andrews Karen L   Pannirselvam Malarvannan   Anderson Todd J   Jenkins Alicia J   Triggle Chris R   Hill Michael A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 101-117

Informa Healthcare

Access to resources Recommend Favorite

Optimizing the Pharmacologic Treatment of Hypertension: BP Control and Target Organ Protection

By Nilsson Peter M.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 287-295

Adis International

Access to resources Recommend Favorite

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

By Sahara Makoto   Takahashi Toshiyuki   Imai Yasushi   Nakajima Toshiaki   Yao Atsushi   Morita Toshihiro   Hirata Yasunobu   Nagai Ryozo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite